Evolve Private Wealth LLC Invests $3.21 Million in HCA Healthcare, Inc. $HCA

Evolve Private Wealth LLC bought a new position in HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 8,224 shares of the company’s stock, valued at approximately $3,207,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Nomura Asset Management Co. Ltd. lifted its position in HCA Healthcare by 6.2% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after purchasing an additional 3,724 shares during the period. Advisors Capital Management LLC raised its stake in shares of HCA Healthcare by 61.5% in the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after buying an additional 2,604 shares in the last quarter. Liberty Wealth Management LLC bought a new position in HCA Healthcare during the fourth quarter valued at about $1,905,000. Arrowstreet Capital Limited Partnership raised its position in HCA Healthcare by 11.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after acquiring an additional 245,887 shares in the last quarter. Finally, Sunbelt Securities Inc. boosted its position in shares of HCA Healthcare by 171.7% during the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock valued at $2,954,000 after purchasing an additional 3,945 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Trading Up 5.6%

NYSE HCA opened at $429.08 on Friday. The company has a market capitalization of $92.90 billion, a PE ratio of 14.36, a price-to-earnings-growth ratio of 1.49 and a beta of 1.10. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52. The firm’s fifty day simple moving average is $397.16 and its 200-day simple moving average is $444.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm’s revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the company earned $6.84 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 29.47 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a $0.78 dividend. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s payout ratio is currently 10.45%.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of research reports. TD Cowen reduced their target price on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a report on Monday, June 22nd. Wells Fargo & Company raised their price objective on HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a research note on Monday, August 3rd. Sanford C. Bernstein reiterated a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Morgan Stanley decreased their target price on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a report on Monday, July 27th. Finally, Truist Financial reduced their price target on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a research report on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $462.64.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.